Evidence from several different experimental systems suggests that regulatory cells specific for self-antigens exist in the normal immune repertoire, and that these cells are necessary for maintenance of self-tolerance and prevention of autoimmune disease. We attempted to demonstrate the existence of regulatory cells specific for central nervous system (CNS) antigens in normal mice. We tested the effects of myelin basic protein (MBP), glial fibrillary acidic protein (GFAP) and a mixture of soluble brain proteins (SBP) on cultured splenocytes. MBP at 50 µg/ml inhibited antigen-driven proliferation and this suppressive effect could be partially blocked by neutralizing antibodies to transforming growth factor (TGF)-β. MBP decreased expression of mRNA for the cytokines IL-2 and IFN-γ, and slightly increased mRNA expression for TGF-β. These effects did not appear to be mediated by regulatory cells specific for MBP, since MBP also suppressed proliferation in MBP-deficient shiverer mice and the suppressive effect could not be reproduced with selected MBP peptides. SBP at 250 µg/ml also inhibited antigen-driven proliferation, but this effect could not be blocked by neutralizing antibodies against IL-4, IL-10 or TGF-β. SBP reduced expression of mRNA for IL-2, IL-10 and TGF-β. These results are more consistent with the presence of a soluble inhibitory factor than with the action of SBP-specific regulatory cells. GFAP had no significant effect on proliferation. These results do not support the existence of regulatory cells specific for CNS antigens. Further investigation into non-antigen-specific mechanisms will be important in defining how autoimmune damage in the CNS is prevented.
Introduction
The immunologic mechanisms which maintain self-tolerance TCR and these cells prevent the occurrence of spontaneous autoimmune disease (8,9). The regulatory cells are CD4, but and prevent autoimmune disease are incompletely understood, but regulatory T lymphocytes may play an important their antigen specificity and mechanism of action is unknown. The regulatory cells described above occur spontaneously, role. Evidence supporting the existence of regulatory T cells in the normal immune repertoire has been demonstrated in and their antigen specificity and mechanism of action is still under investigation. Regulatory T cells can also be several different experimental models. The most convincing evidence for the existence of regulatory T cells as a normal experimentally induced and these cells are better characterized. After recovery from experimental autoimmune part of the immune repertoire has come from models of autoimmune diseases occurring in lymphocyte-depleted encephalomyelitis (EAE), regulatory CD4 cells are present in the spleen of the Lewis rat. These cells protect against the mice. CD4 ϩ CD25 ϩ or CD4 ϩ CD45RB low lymphocytes transferred from normal animals to lymphocyte depleted animals recurrence of EAE, and inhibit lymphocyte proliferation and IFN-γ secretion through a mechanism involving transforming act as regulatory cells and prevent autoimmune disease (1) (2) (3) (4) . CD4 ϩ CD25 ϩ T cells also have regulatory activity in culture growth factor (TGF)-β (10,11). Regulatory CD8 T cells specific for MBP can be induced by oral feeding of MBP (12). These and have been suggested to be a naturally occurring regulatory population (5) (6) (7) . The antigen specificity and mechancells also act through the secretion of TGF-β (13). Based on the above studies, we formed the hypothesis that ism of action of these cells is under investigation. Regulatory T cells have also been demonstrated in mice transgenic for regulatory T cells specific for self-antigens exist in normal adult animals and play an important role in maintaining a TCR specific for myelin basic protein (MBP) . A small number of T cells in these transgenic mice carry a non-transgenic self-tolerance. This should be particularly true for 'immune-privileged' organs such as the central nervous system (CNS). acrylamide gels, combined, concentrated and dialyzed against PBS. These cells should act through secretion of regulatory cytokines such as TGF-β or IL-10, and such cells should exist for After dialysis, all proteins were filtered through a 0.2 µm filter to remove aggregates and ensure sterility, and stored most abundant self-antigens. These cells may be CD25 ϩ . To test the hypothesis, we investigated the effects of CNS selfat -80°C in 1 ml aliquots. An equal number of aliquots of the final dialyzate were filtered and stored for use as controls. antigens on antigen-driven proliferation and cytokine mRNA expression in culture. Since we expected that most CNS Protein concentration was determined using the BCA method (Pierce). antigens should have similar effects, we tested diverse selfantigens with distinct physical properties. MBP is a major MBP1-11, MBP125-135 and MBP136-146 peptides were synthesized commercially (Biosynthesis, Lewisville, TX) using constituent of myelin, and as the name suggests is basic and positively charged at neutral pH. Glial fibrillary acidic protein Fmoc chemistry according to the mouse MBP sequence, and were 85% pure. (GFAP) is a structural protein found in astrocytes, and is acidic and negatively charged at neutral pH. As our third
Proliferation assays antigen, we used soluble proteins extracted from brain tissue (SBP). These proteins are expected to vary in charge and Mice were sacrificed by CO 2 narcosis 10-30 days after immunization and spleens were removed. Splenocytes were mol. wt, and should include proteins expressed throughout the body as well as proteins expressed primarily in the CNS.
cultured at 2ϫ10 5 cells/well in 0.2 ml of HL-1 serum-free media (Biowhittaker, Walkersville, MD) supplemented with 2 mM glutamine, 100 U/ml penicillin, 0.1 mg/ml streptomycin Methods and 5ϫ10 -5 M 2-mercaptoethanol (Gibco, Grand Island, NY).
OVA was used at 200 µg/ml. In a typical experiment, cells Animals were cultured with no antigen, OVA, OVA ϩ one of the CNS DBA/2J and PL/J female mice were obtained from Jackson proteins and OVA ϩ dialyzate from the CNS protein. The Laboratories (Bar Harbor, ME) at age 6 weeks and maintained dialysate from the CNS protein was used as a control for the in microisolator cages. At age 7 weeks or later, mice were possible effects on proliferation due to the PBS or contamininjected s.c. in two sites with a total volume of 0.2 ml of an ants and had only minimal effects on proliferation. Triplicate emulsion containing 0.2 mg/ml ovalbumin (OVA; Sigma, St wells were done with each antigen. [ 3 H]Thymidine (1 µCi) Louis, MO), 0.2 mg/ml Mycobacterium tuberculosis (Difco, was added to each well after 2 days and the cells were Detroit, MI), and equal volumes of saline and incomplete collected on the third day using a semi-automated cell Freund's adjuvant (Difco). MBP-deficient shiverer mice on harvester. The incorporated radioactivity was counted on a the C3HeB/FeJ background were obtained from Jackson scintillation counter. Laboratories at 4 weeks of age and immunized with OVA from
Other tissue culture reagents age 5 to 8 weeks. Heterozygous mice and normal C3HeB/ FeJ mice of the same age were used as controls.
Other reagents used in tissue culture included purified protein derivative of M. tuberculosis (PPD; Parke-Davis, Rochester, CNS antigens and other reagents MI), recombinant murine IL-2 and IFN-γ (R & D Systems, Minneapolis, MN), and neutralizing antibodies against IL-4, MBP was prepared from mouse brains and spinal cords, and purified on a carboxymethylcellulose column as described IL-10 and TGF-β (R & D Systems). Hen egg lysozyme (HEL) and BSA (fraction V; Sigma) were used as non-self-protein (14,15). Column fractions were run on a polyacrylamide gel, and fractions containing MBP were combined, concentrated antigens. in an ultrafiltration cell using a membrane with a nominal mol.
FACS depletion of CD25 ϩ cells wt cut-off of 1 kDa (Amicon, Beverly, MA) and then dialyzed exhaustively against PBS in a dialysis cassette with a mol. wt Spleens were taken from immunized PL/J mice and erythrocytes were removed by density gradient centrifugation over cut-off of 2 kDa (Pierce, Rockford, IL) to remove urea. Forty grams of wet tissue usually yielded about 40 mg of purified Lympholyte-M (Cedarlane, Hornby, Ontario, Canada). Leukocytes from the interface were washed and then suspended protein. Bovine MBP was purified from bovine spinal cord using identical methods.
at 10 7 /ml in HBSS containing 0.1% BSA, and incubated for 30 min on ice with rat anti-mouse CD25-conjugated SBP was prepared from mouse brain. Mice were sacrificed by CO 2 narcosis, perfused with saline and the brains were to phycoerythrin (clone 3C7; PharMingen, San Diego, CA). Excess antibody was removed by washing with HBSS and homogenized in 10 mM HEPES, pH 7.4. The homogenate was centrifuged at 10,000 g for 30 min and then the superstained cells were sorted on a Moflo cell sorter (Cytomation, Boulder, CO) to remove CD25 ϩ cells. After sorting, an aliquot natant was further centrifuged at 100,000 g for 30 min to remove all non-soluble material. The proteins remaining in of cells was checked to ensure that CD25 ϩ cells were depleted as intended. The remainder of the cells were used the supernatant were precipitated by adding ammonium sulfate to 60% saturation. The precipitated proteins were in cell culture as described above. collected by centrifugation, resuspended in water and Preparation of cDNA dialyzed against PBS.
GFAP was isolated using the procedure described for Cells intended for use in competitive PCR were incubated in 96-well plates with antigens at the same concentrations used bovine tissue (16), with the salt gradient modified to 15-100 mM. Fractions containing GFAP were identified on polyin the proliferation assays. After 8 h, cells were resuspended by pipetting and cells from six wells cultured with the same containing ethidium bromide. The gel was photographed under UV illumination using Polaroid type 55 film, and the antigen were combined. The cells were collected by centrifugation and lysed in Trizol (Gibco/BRL, Grand Island, NY). The densities of the construct and target bands on the negative were measured with a densitometer (BioRad, Hercules, CA). wells in the culture plate were also washed with Trizol to extract mRNA from any adherent cells. Lysed cells were Near the point where the construct and target bands were of equal density, the difference in target and construct density frozen at -80°C and total RNA was extracted after results of proliferation assays were available. After extraction, the RNA was approximately a linear function of the log of the construct concentration. The concentration of construct which would was dissolved in 20 µl of water. RNA was reverse transcribed to cDNA using 20 µl RNA, 400 U Superscript II reverse give a band equal in density to the target band was calculated by linear interpolation using the density values for the construct transcriptase (Gibco/BRL), 0.1 U random hexamers (Pharmacia, Piscataway, NJ), 2 µl of 10 mM dNTP (Pharmacia) and concentrations just higher and lower than the target. This concentration was then used to calculate the number of 4 µl of 0.1 M dithiothreitol in a total volume of 40 µl. The reverse transcriptase mixture was incubated at 42°C for 1 h molecules of the target mRNA in the original sample. The lower limit for quantification was between 10 2 -10 3 molecules. and then at 95°C for 5 min.
The cell collection, RNA extraction and reverse transcription PCR primers and constructs steps were done using a uniform methodology, but there could be variations in the efficiency of these steps which The primers used and the sizes of the amplified target and construct DNAs were: actin sense CAT CGT GGG CCG CCC would affect the amount of cytokine mRNA detected. To correct for this possible variation, we also quantified the TAG GCA C, anti-sense CCG GCC AGC CAG GTC CAG ACG C, target 451 bp, construct 274 bp; IL-2 sense TCA amount of actin mRNA present in each sample. The amount of the cytokine mRNA is expressed relative to the amount of AGC TCT ACA GCG GAA GC, anti-sense TGA CAG AAG GCT ATC CAT CTC C, target 401 bp, construct 315 bp; IL-10 actin cDNA present in the same sample. sense GCT GGA CAA CAT ACT GCT AAC CG, anti-sense Because of variations actin construct is the same as described previously (17) in amount of stimulation, percent suppression is used to and the other constructs were synthesized using the actin combine data from different animals. For all data reported construct as a base. Intermediate primers containing the the SI Ͼ 4. In all cases where the effects of different cytokine primer sequence followed by 10 bases of the actin suppressing antigens are compared, the two suppressing construct sequence were used to amplify a new and slightly antigens were tested in the same animals. Values are longer construct with the desired primers at the ends. In some expressed as the mean Ϯ SD of at least three independent cases several different primer pairs were tested to find one experiments. which would amplify both target and construct cleanly without secondary bands which would interfere with the quantification.
Results Concentration of the undiluted construct DNA was determined by comparison of band density on agarose gel of known Effect of brain antigens on antigen-driven proliferation volumes of the construct with the band density of the 383 bp fragment of a BstNI digest of pBR322 (New England BioLabs,
The presence of MBP at a concentration of 50 µg/ml inhibited proliferation to OVA in a reproducible fashion (Figs 1 and 2 ). Beverly, MA). Constructs were serially diluted in 0.5 log unit increments down to 10 -10 of the original concentration for use SBP also inhibited proliferation, with a greater effect at higher concentration. The effects of MBP and SBP were greater in in competitive PCR.
PL/J mice than in DBA/2J mice, although the difference in Competitive PCR the two strains is larger for MBP (P ϭ 0.0008 for MBP and P ϭ 0.017 for SBP 250, t-test). In contrast, GFAP at 100 µg/ The competitive PCR procedure for quantification of mRNA for cytokines was similar to the procedure previously ml had only a minimal effect on proliferation in either strain. The effects of MBP and SBP were not specific to OVA. described (17) . The cDNA and construct were amplified in a 25 µl PCR reaction containing 1 µl cDNA, 5 µl construct, Proliferation to PPD was also inhibited by a similar amount ( Table 1 ). The suppressive effect was not simply due to the 1.25 U Taq polymerase (Perkin-Elmer, Foster City, CA), 12.5 pmol of each primer, 2.5 µl 10ϫPCR buffer and 0.5 µl 10 mM presence of additional protein, since addition of non-selfproteins had little effect on proliferation to OVA. HEL at 250 dNTP. Amplification was carried out for 35 cycles of 94°C for 60 s, then 55°C for 90 s, then 72°C for 90 s in a 96-well µg/ml suppressed proliferation by only 4 Ϯ 14% (n ϭ 5) and 250 µg/ml BSA suppressed proliferation by 0 Ϯ 13% (n ϭ 4). thermal cycler (Stratagene, La Jolla, CA). For each cytokine, three to four reactions were performed using serial dilutions Neither MBP nor SBP alone had much effect on background proliferation. In the PL/J strain, the SI with MBP was 0.96 Ϯ of construct covering the expected target concentration and the resulting PCR products were resolved on an agarose gel 0.44 (n ϭ 9) and the SI with SBP was 1.51 Ϯ 0.64 (n ϭ 6). Neutralizing anti-TGF-β antibody partially blocks MBP suppression (P ϭ 0.008, paired t-test). Antibodies to IL-4 or IL-10 had no effect. splenocytes from a single PL/J mouse to no antigen and to OVA ϩ different CNS proteins. To ensure the effects on proliferation are due Bars indicate mean percent suppression, error bars indicate SD, n ϭ 7. to the protein, the final dialyzate from each protein is used as a control. Each CNS protein is compared to an equal volume of its own dialyzate. As expected, the dialyzates had little effect on proliferation to OVA in the quantities used (5-13 µl/well). In this example, MBP at 50 µg/ml suppressed 57%, SBP at 250 µg/ml suppressed 80% and amino acids and the main form of bovine MBP has 169 amino acids. The proteins are very similar in amino acid composition 
Neutralizing anti-TGF antibody partially blocks MBP suppression Murine MBP is more effective than bovine MBP
We investigated whether the regulatory cytokines IL-4, IL-10 or TGF-β were involved in the suppression of proliferation in As an additional control for the comparison of self-and nonself-proteins, we compared the effects of murine and bovine PL/J mice. Anti-cytokine antibodies at 10 µg/ml were added to cells cultured with OVA alone or with OVA ϩ one of the MBP. In both species, MBP consists of several isoforms which are produced by differential splicing of the mRNA from a CNS antigens. The anti-TGF antibody partially blocked the suppressive effect of MBP, reducing the percent suppression single gene. The major form of MBP in the mouse has 127 with OVA ϩ SBP demonstrates a different effect of SBP than MBP (Fig. 7) . Like MBP, SBP reduces IL-2 (P ϭ 0.002, paired n ϭ 6 for MBP and n ϭ 4 for SBP.
t-test)
, but the effects on the other cytokines differ. IFN-γ shows no consistent change, IL-10 decreases (P ϭ 0.032) and TGF-β shows a trend towards a decrease (P ϭ 0.059) rather than the increase seen with MBP. from 67 Ϯ 15 to 43 Ϯ 11 (Fig. 3) . The anti-TGF antibody also increased the mean SI to OVA from 9.8 Ϯ 1.8 to 11.2 Ϯ 2.1, Suppression is not mediated by CD25 ϩ cells suggesting that there is some baseline secretion of TGF by cultured cells which limits the proliferative response. A control Because of the reports of others that CD25 ϩ cells might antibody of the same isotype as the anti-TGF-β had no effect represent a naturally occurring regulatory population, we on proliferation or MBP suppression. The percent suppression investigated whether the effects of MBP and SBP were was 64 Ϯ 9 with no antibody and 63 Ϯ 8 with the isotype mediated by CD25 ϩ cells. CD25 ϩ cells were depleted by cell control (n ϭ 6). In similar experiments with SBP, none of the sorting and the response of CD25 -splenocytes was compared antibodies blocked suppression. The percent suppression to that of unfractionated splenocytes from the same animal. without antibody was 67 Ϯ 11 and it did not change significPercent suppression by MBP was 83 Ϯ 5 for unfractionated antly with any of the antibodies (n ϭ 5).
splenocytes and 90 Ϯ 6 in CD25 -cells (n ϭ 3). Percent suppression by SBP was 79 Ϯ 6 for unfractionated cells and
Addition of IL-2 does not reverse suppression 79 Ϯ 15 for CD25 -cells (n ϭ 2). Other investigators have suggested that self-antigen-specific regulatory cells might act by blocking the secretion of IL-2
The effect of MBP cannot be reproduced with selected and that their effect could be reversed by the addition of IL-2.
peptides We tested the effects of both IL-2 and IFN-γ on MBP and SBP If MBP suppresses proliferation through the activation of MBPsuppression. The addition of 10 ng/ml IL-2 approximately specific regulatory cells, then MBP peptides containing the doubled the proliferative response to OVA. Proliferation with suppressive epitope should also suppress proliferation. We OVA and CNS antigen increased by a proportional amount, tested the effect of three different peptides on proliferation to so the percent suppression did not change (Table 3) .
OVA. The MBP125-135 and MBP136-146 peptides are the immunodominant epitopes in MBP-deficient H-2 u mice, and Competitive PCR for cytokine mRNA are known to bind stably to I-A u and induce tolerance in wildTo further investigate the effects of brain antigens, we used type H-2 u mice (18,19). Cultured T cells specific for these competitive PCR to measure the effects of brain antigens on peptides cause EAE in wild-type H-2 u mice, so these peptides the expression of cytokine mRNA. Cells were cultured with must be presented in vivo. These two peptides are therefore either no antigen, OVA, OVA ϩ MBP or MBP for 8 h before leading candidates for regulatory epitopes of MBP. The MBP1-they were collected for mRNA extraction. To correct for 11 peptide is a subdominant epitope in MBP-deficient H-2 u possible variations in the efficiency in the processing of the mice and the dominant epitope in wild-type H-2 u mice. MBP1-specimens to cDNA, the concentration of cytokine mRNA in 11 is less effective in inducing tolerance, but it is also each sample is expressed relative to the concentration of encephalitogenic. actin mRNA in the same sample. Cells cultured with no None of the three peptides had any significant effect on antigen had measurable amounts of mRNA for IL-2, IL-10 proliferation. The percent suppression was -6 Ϯ 14 with and TGF-β; but IFN-γ mRNA was undetectable in seven of MBP1-11, 1 Ϯ 14 with MBP125-135 and 5 Ϯ 7 with MBP136-the eight samples (Fig. 4) . Addition of OVA markedly increased 146 with the peptides at 100 µg/ml. In the same mice, MBP mRNA for IL-2 and IFN-γ, but had no consistent effect on at 50 µg/ml suppressed proliferation by 65 Ϯ 13%. In further IL-10 or TGF-β. Culture with MBP alone caused IL-2 to become experiments, none of the peptides had any effect on proliferaundetectable in all eight samples, but had no consistent effect tion at 200 µg/ml nor was there any effect when the three on the other cytokines in comparison to no antigen. IFN-γ peptides were used in combination. remained undetectable in the majority of samples cultured with MBP.
MBP suppresses proliferation in MBP-deficient shiverer mice Comparison of mRNA concentrations in cells cultured with OVA or OVA ϩ MBP reveals some interesting findings (Fig. To further investigate the mechanism of suppression, we tested the effect of MBP and SBP in shiverer mice which do 5). The addition of MBP to OVA-stimulated cells decreased the concentration of mRNA for IL-2 and IFN-γ, and increased not express MBP. We expected that SBP should suppress proliferation in these mice, but that MBP should not. SBP the concentration of mRNA for TGF-β (P ϭ 0.020 for IL-2, 0.005 for IFN-γ and P ϭ 0.015 for TGF-β, paired t-test). There suppressed proliferation to OVA by 79 Ϯ 28% as expected and MBP suppressed proliferation 65 Ϯ 14% (n ϭ 4). This was was no consistent change in IL-10. normal immune repertoire and should have demonstrable effects in culture. Our experimental results do not support this hypothesis. GFAP had no significant suppressive effect, and the suppressive effects of MBP and SBP do not appear to be mediated through regulatory T cells.
Our initial results with MBP seemed to support the existence of MBP-specific regulatory cells. MBP in relatively low concentrations inhibited proliferation, decreased expression of mRNA for the inflammatory cytokines IL-2 and IFN-γ, and increased expression of mRNA for TGF-β. The effect of MBP could be partially blocked by antibody against TGF-β, providing further support for the role of this cytokine as a mediator of MBP suppression. The effect of murine MBP was greater than bovine MBP, suggesting that the exact amino acid sequence might be more important for the suppressive effect than the unique physical properties shared by bovine and murine MBP.
However, our subsequent investigations did not support through a non-antigen-specific mechanism. Our results with the MBP peptides also failed to support our hypothesis. Based on the available knowledge of the processing, binding and presentation of MBP epitopes in H-2 u mice, the three peptides not significantly different from the suppression in heterozygote tested are the most likely regulatory epitopes. However, none and wild-type controls assayed at the same time.
of these three peptides had any effect on proliferation. This does not conclusively rule out the existence of a regulatory Discussion epitope in MBP since we did not test peptides covering the entire MBP molecule. The depletion of CD25 ϩ cells had no We began this work with the hypothesis that regulatory T cells specific for abundant CNS antigens should be present in the effect on MBP suppression, suggesting that MBP does not SBP does suppress proliferation, but the concentrations required are high and there is no evidence for the involvement of regulatory cytokines. One possible explanation is that SBP contains one or more of the soluble immunosuppressive factors reported to be present within the CNS. Further experiments in which SBP is separated into fractions will be required to verify this. Taken together, our results with MBP, SBP and GFAP do not support the hypothesis that regulatory cells specific for self-antigens exist in the normal immune system. It is possible that such cells do exist, but that our methods were inadequate to demonstrate their presence. This could occur if these cells required some signal for activity which is present in vivo but not in tissue culture. For example, regulatory cells might require contact with a normal extracellular matrix for activity. It is also possible that such regulatory cells exist, but are specific for antigens other than MBP, SBP and GFAP. Another of in vivo regulatory activity.
It is also possible that regulatory cells specific for selfantigen are not a part of the normal immune repertoire. selectively stimulate the putative natural regulatory population
Although not the expected result, this conclusion is consistent of CD4 ϩ CD25 ϩ cells.
both with the present work and with the work by others These results suggest that the effects of MBP are not discussed in the Introduction. The spontaneously occurring mediated through the action of MBP specific regulatory cells. regulatory cells described in various experimental systems There are several plausible alternative explanations. MBP is are defined by their ability to prevent autoimmune disease known to bind to MHC class II molecules and could in vivo, but their antigen specificity has not been defined. In conceivably block the presentation of OVA to T cells (20) .
some cases these cells appeared to be tissue specific (21, 22 ), The positively charged MBP molecule might also bind nonbut the relevant antigen has never been directly demonstrated. specifically to negatively charged cell membranes and the In cases where the specific antigen is known, the regulatory tissue culture plate, and interfere with cell-cell interactions or cells are not present in normal animals, but are found only cell migration. In support of this explanation, we have found after experimental manipulation such as induction of EAE or that other molecules with a similar degree of net positive oral tolerization. It is also possible that such cells exist for charge, including histones and glatiramer acetate (formerly systemic antigens, but not for sequestered CNS antigens. known as copolymer-1), have a similar suppressive effect on If CNS antigen-specific regulatory cells are not present in proliferation in culture (data not shown).
The results with SBP also do not support our hypothesis. the normal immune repertoire, then there must be other research. One possibility is that immunoregulatory molecules
